NVCR
$11.77
Revenue | $158.81Mn |
Net Profits | $-40.14Mn |
Net Profit Margins | -25.28% |
Novocure Limited’s revenue jumped 5.62% since last year same period to $158.81Mn in the Q2 2025. On a quarterly growth basis, Novocure Limited has generated 2.46% jump in its revenue since last 3-months.
Novocure Limited’s net profit fell -20.27% since last year same period to $-40.14Mn in the Q2 2025. On a quarterly growth basis, Novocure Limited has generated -16.96% fall in its net profits since last 3-months.
Novocure Limited’s net profit margin fell -13.87% since last year same period to -25.28% in the Q2 2025. On a quarterly growth basis, Novocure Limited has generated -14.15% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.43 |
EPS Estimate Current Year | -0.43 |
Novocure Limited’s earning per share (EPS) estimates for the current quarter stand at -0.43 - a -12.37% fall from last quarter’s estimates.
Novocure Limited’s earning per share (EPS) estimates for the current year stand at -0.43.
Earning Per Share (EPS) | 0 |
Novocure Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Novocure Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-07-24 | -0.38 | -0.36 | 5.26% |
2025-04-24 | -0.46 | -0.31 | 33.19% |
2025-10-23 | -0.43 | 0 | 100% |